Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

{{article.zuoZheEn}}

PDF(729 KB)
PDF(729 KB)
Protein Cell ›› 2018, Vol. 9 ›› Issue (10) : 838-847. DOI: 10.1007/s13238-017-0440-4
RESEARCH ARTICLE

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Protein Cell, 2018, 9(10): 838‒847 https://doi.org/10.1007/s13238-017-0440-4

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(729 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉